CD226 and neoplasm: NKG2D-based CARs target stress-induced ligands such as MHC class I–related chain A/B (MICA/B) and UL16-binding proteins (ULBPs), whereas DNAM-1 chimeras enhance adhesion and immune synapse formation, improving serial cytotoxicity against resistant tumor cells (62).